CXSE
WisdomTree China ex-State-Owned Enterprises Fund
WisdomTree China ex-State-Owned Enterprises Fund seeks to track the investment results of Chinese companies that are not state-owned enterprises, which is defined as government ownership of greater than 20%.
Emerging Market
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 497.0 M
ASSETS UNDER MGMT
32 bp
EXPENSES
Fund Basics
| Inception date | Sep 19, 2012 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| TENCENT HOLDINGS LTD | 7.3 % |
| ALIBABA GROUP HOLDING LTD. | 6.5 % |
| ZHONGJI INNOLIGHT CO., LTD. CLASS A | 5.6 % |
| CONTEMPORARY AMPEREX TECHNOLOGY CO., LTD | 4.6 % |
| EOPTOLINK TECHNOLOGY INC., LTD. CLASS A | 3.1 % |
| PING AN INSURANCE (GROUP) COMPANY OF CHI | 2.1 % |
| CAMBRICON TECHNOLOGIES CORP. LTD. CLASS | 1.9 % |
| PINDUODUO, INC. SPONSORED ADR CLASS A | 1.9 % |
| XIAOMI CORP. CLASS B | 1.7 % |
| MEITUAN DIANPING | 1.6 % |
Constituent Breakdown
| Number of holdings | 261 |
| Herfindahl-Hirschman Index | 212 |
| Wgt avg mkt cap (mns) | $107,085 |
| Large cap (>$10bn) | 80.6% |
| Mid cap ($2-10bn) | 13.2% |
| Small cap (<$2bn) | 2.2% |
| Developed mkts. | 5.3% |
| Emerging mkts. | 91.6% |
Sector Breakdown
Country Exposure
 |
CHINA | 91.6 % |
 |
HONG KONG | 5.2 % |
Historical Performance
Standardized Performance (as of 07/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -4.5% | 3.5% | 20.5% | 3.4% | -7.8% | 5.0% | -- | -49.5% |
| Dividend Yield | 0.3% | 1.5% | 1.9% | 1.7% | 1.4% | 1.4% | -- | -1.8% |
| Total Returns | -4.2% | 5.0% | 22.4% | 5.1% | -6.4% | 6.4% | -- | -51.3% | Ann. Volatility | 22.7% | 22.6% | 30.0% | 28.4% | 32.0% | 28.8% | -- | 38.4% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.01 | 33% |
| MSCI EAFE | 0.81 | 32% |
| MSCI Emg Mkts | 0.67 | 52% |
Liquidity Measures
| Avg. volume (000) | 31 |
| ADV traded (mns) | $1 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.19% |
Technical Indicators
| 30d moving avg. (EMA) | $38.34 |
| Relative strength (RSI) | 49 |
| MACD/Signal | -0.23/-0.28 |
| Bollinger Bands (Upper/Lower) | $39.08/$37.20 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. CXSE |
Expenses vs. CXSE |
ALTAR Score™ vs. CXSE |
|---|---|---|---|---|
| FLCH | Franklin FTSE China ETF | 47.0% | -13 bp | +3.6% |
| ASHR | Xtrackers Harvest CSI 300 China A-Shares ETF | 42.7% | +33 bp | -9.3% |
| TCHI | iShares MSCI China Multisector Tech ETF | 42.7% | +27 bp | +0.2% |
| GXC | SPDR S & P China ETF | 38.8% | +27 bp | +4.7% |
| MCHI | iShares MSCI China ETF | 38.8% | +27 bp | +6.1% |
| JCHI | JPMorgan Active China ETF | 37.4% | +33 bp | +0.6% |
| MCH | Matthews China Active ETF | 35.2% | +47 bp | -0.2% |
| BKF | iShares MSCI BIC ETF | 29.2% | +37 bp | 0.0% |
| KBA | KraneShares Bosera MSCI China A 50 Connect Index ETF | 28.9% | +23 bp | -9.1% |
| FXI | iShares China Large-Cap ETF | 27.3% | +42 bp | +6.6% |
Risk and Returns: CXSE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 8/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
15.9%
ALTAR SCORE™
99th
PERCENTILE
SPECULATIVE
ETFRC RATING
There are 214 funds in the Emerging Equity category with an average
ALTAR Score™ of 7.6% and a standard deviation
of 2.2%. CXSE's ALTAR Score™ is approximately 3.7 standard
deviations above the category average. This places CXSE in the 99th percentile
among funds in the category.
Sell-Side Consensus
$55.65
PRICE TARGET
+43.1%
UPSIDE